Journal of Clinical Virology
Volume 47, Issue 1 , Pages 72-75 , January 2010

Hepatitis C virus RNA localization in human carotid plaques

  • Maria Boddi

      Affiliations

    • Clinica Medica Generale e Cardiologia, Department of Medical and Surgical Critical Care, University of Florence, Italy
    • ,
  • Rosanna Abbate

      Affiliations

    • Thrombosis Centre, Azienda Ospedaliero-Universitaria Careggi, Florence and Center for the Study at Molecular and Clinical Level of Chronic, Degenerative and Neoplastic Diseases to Develop Novel Therapies, University of Florence, Italy
    • ,
  • Benedetta Chellini

      Affiliations

    • Clinica Medica Generale e Cardiologia, Department of Medical and Surgical Critical Care, University of Florence, Italy
    • ,
  • Betti Giusti

      Affiliations

    • Thrombosis Centre, Azienda Ospedaliero-Universitaria Careggi, Florence and Center for the Study at Molecular and Clinical Level of Chronic, Degenerative and Neoplastic Diseases to Develop Novel Therapies, University of Florence, Italy
    • ,
  • Carlo Giannini

      Affiliations

    • Center for Systemic Manifestations of Hepatitis Viruses (MASVE), Department of Internal Medicine, University of Florence, Viale Morgagni 85, 50134 Florence, Italy
    • ,
  • Giovanni Pratesi

      Affiliations

    • Unit of Vascular Surgery, Department of Medical and Surgical Critical Care, University of Florence, Italy
    • ,
  • Luciana Rossi

      Affiliations

    • Thrombosis Centre, Azienda Ospedaliero-Universitaria Careggi, Florence and Center for the Study at Molecular and Clinical Level of Chronic, Degenerative and Neoplastic Diseases to Develop Novel Therapies, University of Florence, Italy
    • ,
  • Carlo Pratesi

      Affiliations

    • Unit of Vascular Surgery, Department of Medical and Surgical Critical Care, University of Florence, Italy
    • ,
  • Gian Franco Gensini

      Affiliations

    • Clinica Medica Generale e Cardiologia, Department of Medical and Surgical Critical Care, University of Florence, Italy
    • Fondazione Don Carlo Gnocchi, Centro S. Maria degli Ulivi, Firenze, Italy
    • ,
  • Laura Paperetti

      Affiliations

    • Clinica Medica Generale e Cardiologia, Department of Medical and Surgical Critical Care, University of Florence, Italy
    • ,
  • Anna Linda Zignego

      Affiliations

    • Center for Systemic Manifestations of Hepatitis Viruses (MASVE), Department of Internal Medicine, University of Florence, Viale Morgagni 85, 50134 Florence, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 055 4271077; +39 055 7947335.

Received 15 April 2009 ,Revised 8 September 2009 ,Accepted 7 October 2009.

References 

  1. Fabricant CG, Fabricant J, Litrenta MM, Minick CR. Virus-induced atherosclerosis. J Exp Med. 1978;148:335–340
  2. Ross R. Atherosclerosis—an inflammatory disease. N Engl J Med. 1999;340:115–126
  3. Espinola-Klein C, Rupprecht HJ, Blankenberg S, Bickel C, Kopp H, Victor A, et al. Impact of infectious burden on progression of carotid atherosclerosis. Stroke. 2002;33:2581–2586
  4. Prasad A, Zhu J, Halcox JP, Waclawiw MA, Epstein SE, Quyyumi AA. Predisposition to atherosclerosis by infections: role of endothelial dysfunction. Circulation. 2002;106:184–190
  5. Kalayoglu MV, Libby P, Byrne GI. Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease. JAMA. 2002;288:2724–2731
  6. Gibson FC, Genco CA. Porphyromonas gingivalis mediated periodontal disease and atherosclerosis: disparate diseases with commonalities in pathogenesis through TLRs. Curr Pharm Des. 2007;13:3665–3675
  7. Hendrix MG, Salimans MM, van Boven CP, Bruggeman CA. High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis. Am J Pathol. 1990;136:23–28
  8. Stoll G, Bendszus M. Inflammation and atherosclerosis: novel insights into plaque formation and destabilization. Stroke. 2006;37:1923–1932
  9. Froberg MK, Adams A, Seacotte N, Parker-Thornburg J, Kolattukudy P. Cytomegalovirus infection accelerates inflammation in vascular tissue overexpressing monocyte chemoattractant protein-1. Circ Res. 2001;89:1224–1230
  10. Zignego AL, Craxi A. Extrahepatic manifestations of hepatitis C virus infection. Clin Liver Dis. 2008;12:611–636ix
  11. Zignego AL, Giannini C, Monti M, Gragnani L. Hepatitis C virus lymphotropism: lessons from a decade of studies. Dig Liver Dis. 2007;39(Suppl 1):S38–45
  12. Pham TN, MacParland SA, Mulrooney PM, Cooksley H, Naoumov NV, Michalak TI. Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C. J Virol. 2004;78:5867–5874
  13. Radkowski M, Gallegos-Orozco JF, Jablonska J, Colby TV, Walewska-Zielecka B, Kubicka J, et al. Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C. Hepatology. 2005;41:106–114
  14. Giannini C, Petrarca A, Monti M, Arena U, Caini P, Solazzo V, et al. Association between persistent lymphatic infection by hepatitis C virus after antiviral treatment and mixed cryoglobulinemia. Blood. 2008;111:2943–2945
  15. Agnello V, Abel G, Elfahal M, Knight GB, Zhang QX. Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc Natl Acad Sci USA. 1999;96:12766–12771
  16. Voisset C, Callens N, Blanchard E, Op De Beeck A, Dubuisson J, Vu-Dac N. High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I. J Biol Chem. 2005;280:7793–7799
  17. Peng YS, Chiang CK, Hsu SP, Pai MF, Hung KY, Kao JH. Influence of hepatitis C virus infection on soluble cellular adhesion molecules in hemodialysis patients. Blood Purif. 2005;23:106–112
  18. Tardif KD, Waris G, Siddiqui A. Hepatitis C virus, ER stress, and oxidative stress. Trends Microbiol. 2005;13:159–163
  19. Ishizaka N, Ishizaka Y, Takahashi E, Tooda E, Hashimoto H, Nagai R, et al. Association between hepatitis C virus seropositivity, carotid-artery plaque, and intima–media thickening. Lancet. 2002;359:133–135
  20. Ishizaka Y, Ishizaka N, Takahashi E, Unuma T, Tooda E, Hashimoto H, et al. Association between hepatitis C virus core protein and carotid atherosclerosis. Circ J. 2003;67:26–30
  21. Bilora F, Rinaldi R, Boccioletti V, Petrobelli F, Girolami A. Chronic viral hepatitis: a prospective factor against atherosclerosis. A study with echo-color Doppler of the carotid and femoral arteries and the abdominal aorta. Gastroenterol Clin Biol. 2002;26:1001–1004
  22. Vassalle C, Masini S, Bianchi F, Zucchelli GC. Evidence for association between hepatitis C virus seropositivity and coronary artery disease. Heart. 2004;90:565–566
  23. Boddi M, Abbate R, Chellini B, Giusti B, Solazzo V, Soft F, et al. HCV infection facilitates asymptomatic carotid atherosclerosis: preliminary report of HCV RNA localization in human carotid plaques. Dig Liver Dis. 2007;39(Suppl 1):S55–60
  24. Zignego AL, Ferri C, Giannelli F, Giannini C, Caini P, Monti M, et al. Prevalence of bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas. Ann Intern Med. 2002;137:571–580
  25. Giannelli F, Moscarella S, Giannini C, Caini P, Monti M, Gragnani L, et al. Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation. Blood. 2003;102:1196–1201
  26. Radkowski M, Bednarska A, Horban A, Stanczak J, Wilkinson J, Adair DM, et al. Infection of primary human macrophages with hepatitis C virus in vitro: induction of tumour necrosis factor-alpha and interleukin 8. J Gen Virol. 2004;85:47–59
  27. Zignego AL, Ferri C, Giannini C, Monti M, La Civita L, Careccia G, et al. Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia. Ann Intern Med. 1996;124:31–34
  28. Giannini C, Giannelli F, Monti M, Careccia G, Marrocchi ME, Laffi G, et al. Prevalence of mixed infection by different hepatitis C virus genotypes in patients with hepatitis C virus-related chronic liver disease. J Lab Clin Med. 1999;134:68–73
  29. Ansaldi F, Bruzzone B, Salmaso S, Rota MC, Durando P, Gasparini R, et al. Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy. J Med Virol. 2005;76:327–332
  30. Kono Y, Hayashida K, Tanaka H, Ishibashi H, Harada M. High-density lipoprotein binding rate differs greatly between genotypes 1b and 2a/2b of hepatitis C virus. J Med Virol. 2003;70:42–48
  31. Zignego AL, Macchia D, Monti M, Thiers V, Mazzetti M, Foschi M, et al. Infection of peripheral mononuclear blood cells by hepatitis C virus. J Hepatol. 1992;15:382–386[see comments]
  32. Zignego AL, Ferri C, Monti M, LaCivita L, Giannini C, Careccia G, et al. Hepatitis C virus as a lymphotropic agent: evidence and pathogenetic implications. Clin Exp Rheumatol. 1995;13:S33–S37

PII: S1386-6532(09)00495-8

doi: 10.1016/j.jcv.2009.10.005

Journal of Clinical Virology
Volume 47, Issue 1 , Pages 72-75 , January 2010

Article Tools

* Image Usage & Resolution